ZVRA logo

Zevra Therapeutics, Inc. Common Stock


ZVRA: Zevra Therapeutics Inc is a rare disease company melding science, data and patient needs to create transformational therapies for diseases with limited or no treatment options. The firm's data-driven clinical, regulatory, and commercialization strategies overcome complex drug development challenges to bring much-needed therapies to patients. Its product candidate comprises Arimoclomol, orally delivered investigational product candidate for the treatment of Niemann-Pick type C (NPC). KP1077 is Zevra's lead clinical candidate being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy.


Show ZVRA Financials

Consumer Interest
SEC Filings

Recent trades of ZVRA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by ZVRA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Ketamine compounds and processes for making and using them Sep. 12, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ZVRA in WallStreetBets Daily Discussion


Recent insights relating to ZVRA

CNBC Recommendations

Recent picks made for ZVRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ZVRA

Corporate Flights

Flights by private jets registered to ZVRA